Skip to main content
. 2021 Jun 17;21(4):401–409. doi: 10.1097/ACI.0000000000000762

Table 1.

COVID-19 vaccines mentioned in the text and used for mass vaccination in Europe

Product type Manufacturer and name Suspected culprit allergen
mRNA vaccine Pfizer/BioNTech, BNT16262, BioNTechManufacturing GmbH Mainz Germany and Pfizer Manufacturing GmbH Puurs, Belgium, ‘Comirnaty’ COVID-19 Vaccine Moderna, Moderna Biotech Spain, Madrid, Spain Polyethylene glycol (PEG-2000)
Adenovirus vector vaccine AstraZeneca, AZD1222, AstraZeneca AB, Södertälje, Sweden, ‘Vaxzevria’ COVID-19 Vaccine Janssen, Ad26.COV2-S, Janssen-Cilag International NV, Beerre, Belgium Sputnik V, Gamaleya Research Institute of Epidemiology and Mirobiology, Moscow, Russia Polysorbate 80
Inactivated virus BBIBP-CorV, Beijing Institute of Biological Products, Beijing, China, ‘Sinopharm’
Recombinant spike protein Novavax COVID-19 Vaccine, NVX-COV2373, Novavax Inc, Gaithersburg, Maryland, USA Polysorbate 80

Note: BBIBP-CorV does not contain polyethylene glycol or polysorbate 80. PEG, polyethylene glycol.